Company Filing History:
Years Active: 2018
Title: Daisuke Hirano: Innovator in Cancer Treatment
Introduction
Daisuke Hirano is a prominent inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. His innovative work focuses on developing therapies for patients with FLT3 mutation-positive cancer.
Latest Patents
Daisuke Hirano holds 1 patent for a pharmaceutical composition aimed at treating FLT3 mutation-positive cancer. This patent includes a mutant FLT3 inhibitor and outlines various methods for predicting therapeutic effects and selecting suitable subjects for treatment. The composition contains a compound represented by General Formula [1] or a salt thereof as an active ingredient.
Career Highlights
Hirano is currently employed at Fujifilm Corporation, where he continues to advance his research in cancer therapies. His work has the potential to significantly impact the lives of patients suffering from specific types of cancer.
Collaborations
Daisuke Hirano collaborates with notable colleagues, including Tomoki Naoe and Hitoshi Kiyoi. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Daisuke Hirano's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work at Fujifilm Corporation and collaborations with esteemed colleagues further solidify his role as a key figure in pharmaceutical innovation.